Quell launches chill phase 1/2 trial for novel cartreg therapy
3rd March 2026 Uncategorised 0
Company targets new approach to treating rheumatoid arthritis and systemic sclerosis

More: Quell launches chill phase 1/2 trial for novel cartreg therapy
Source: News
